Changes in Gastric Inhibitory Polypeptide (GIP) After Roux-en-Y Gastric Bypass in Obese Patients: a Meta-analysis

Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial

(2021) Geltrude Mingrone et al.   LANCET

Epidemiology and determinants of obesity in China

(2021) Xiong-Fei Pan et al.   Lancet Diabetes & Endocrinology

Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass

(2020) Kathleen M. McTigue et al.   JAMA Surgery

Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study

(2020) Kleopatra Alexiadou et al.   BMJ Open Diabetes Research & Care

Dipeptidyl peptidase-4 activity, lipopolysaccharide, C-reactive protein, glucose metabolism, and gut peptides 3 months after bariatric surgery

(2020) Tassia Gomide Braga et al.   Surgery for Obesity and Related Diseases

Systematic Review and Meta-analysis of the Change in Ghrelin Levels After Roux-en-Y Gastric Bypass

(2019) Hang-Cheng Xu et al.   OBESITY SURGERY

Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass

(2018) Jonathan Q. Purnell et al.   DIABETOLOGIA

Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different

(2018) A. Pucci et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy

(2017) Pichamol Jirapinyo et al.   OBESITY SURGERY

Gastric Bypass Reduces Symptoms and Hormonal Responses in Hypoglycemia

(2016) Niclas Abrahamsson et al.   DIABETES

Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study

(2016) G. Nosso et al.   HORMONE AND METABOLIC RESEARCH

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

(2016)   LANCET

The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones

(2016) Claire L Meek et al.   PEPTIDES

Comparison of Short- and Mid-term Efficacy and the Mechanisms of Gastric Bypass Surgeries on Managing Obese and Nonobese Type 2 Diabetes Mellitus: A Prospective Study

(2015) Xiaojuan Zhang et al.   ARCHIVES OF MEDICAL RESEARCH

Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial

(2015) Geltrude Mingrone et al.   LANCET

GLP-1 Plays a Limited Role in Improved Glycemia Shortly After Roux-en-Y Gastric Bypass: A Comparison With Intensive Lifestyle Modification

(2014) Marion L. Vetter et al.   DIABETES

Calorie Restriction is a Major Determinant of the Short-Term Metabolic Effects of Gastric Bypass Surgery in Obese Type 2 Diabetic Patients

(2013) Mirjam A. Lips et al.   CLINICAL ENDOCRINOLOGY

Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass

(2013) Carsten Dirksen et al.   DIABETOLOGIA

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance

(2012) N. B. Jørgensen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

(2012) C. Dirksen et al.   DIABETOLOGIA

Changes in Gastrointestinal Hormone Responses, Insulin Sensitivity, and Beta-Cell Function Within 2 Weeks After Gastric Bypass in Non-diabetic Subjects

(2012) S. H. Jacobsen et al.   OBESITY SURGERY

Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects

(2012) Fabiola Romero et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Changes of blood glucose and gastrointestinal hormones 4 months after Roux-en-Y gastric bypass surgery in Chinese obese type 2 diabetes patients with lower body mass index

(2012) Qianlin Wu et al.   Journal of Diabetes Investigation

Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery

(2011) Erik N. Hansen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The Effects of an Amino Acid Supplement on Glucose Homeostasis, Inflammatory Markers, and Incretins after Laparoscopic Gastric Bypass

(2011) Igal Breitman et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

The Importance of Caloric Restriction in the Early Improvements in Insulin Sensitivity After Roux-en-Y Gastric Bypass Surgery: Response to Ozer, Abdelnour, and Alva

(2010) R. A. Tamboli et al.   DIABETES CARE

GIP and Bariatric Surgery

(2010) Raghavendra S. Rao et al.   OBESITY SURGERY

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

(2010) David Moher et al.   International Journal of Surgery

Mechanisms of Weight Loss after Gastric Bypass and Gastric Banding

(2009) Marco Bueter et al.   Obesity Facts

Effect of Weight Loss by Gastric Bypass SurgeryVersusHypocaloric Diet on Glucose and Incretin Levels in Patients with Type 2 Diabetes

(2008) Blandine Laferrère et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM